Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Wolkenstein

Showing results (11-20 of 230) with videos related to

Pageof 23
Sort By:
Contact Dermatitis|January 10, 2019
Severe contact allergy to mupirocin in a polysensitized patientHaudrey Assier, Gaëlle Hirsch, Pierre Wolkenstein, et al.
Orphanet Journal of Rare Diseases|July 16, 2020
Neurofibromatosis I and multiple sclerosisChristina Bergqvist, François Hemery, Salah Ferkal, et al.
Journal of Medical Genetics|August 15, 2012
Neurofibromatosis type 1: from genotype to phenotypeEric Pasmant, Michel Vidaud, Dominique Vidaud, et al.
Contact Dermatitis|June 14, 2014
Contact dermatitis caused by ascorbyl tetraisopalmitate in a cream used for the management of atopic dermatitisHaudrey Assier, Pierre Wolkenstein, Catherine Grille, et al.
The Journal of Investigative Dermatology|February 28, 2025
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: How to Improve the Evaluation of Therapeutic StrategiesSaskia Ingen-Housz-Oro, Lars E French, Pierre Wolkenstein
The Journal of Investigative Dermatology|January 23, 2025
Need for Trial Design Change in Epidermal Necrolysis (Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis): Example of CyclosporineSaskia Ingen-Housz-Oro, Nicolas de Prost, Pierre Wolkenstein
Presse Medicale (Paris, France : 1983)|March 14, 2018
[Association of chromhidrosis and segmental neurofibromatosis]Charles Velter, Sylvie Thubert, Pierre Wolkenstein, et al.
Neuro-Oncology Advances|March 9, 2026
Disease burden and unmet needs in adults with neurofibromatosis type 1 and plexiform neurofibromas: A systematic literature reviewMaciej Mrugala, Ayo Adeyemi, Juliet Johns, et al.
Journal of the American Academy of Dermatology|November 14, 2006
Quality of life impairment in hidradenitis suppurativa: a study of 61 casesPierre Wolkenstein, Anderson Loundou, Karine Barrau, et al.
Orphanet Journal of Rare Diseases|May 20, 2021
Lymphoproliferative malignancies in patients with neurofibromatosis 1Christina Bergqvist, François Hemery, Arnaud Jannic, et al.
Pageof 23

Showing results (11-20 of 230) with videos related to

Sort By:
Pageof 23
Contact Dermatitis|January 10, 2019
Severe contact allergy to mupirocin in a polysensitized patientHaudrey Assier, Gaëlle Hirsch, Pierre Wolkenstein, et al.
Orphanet Journal of Rare Diseases|July 16, 2020
Neurofibromatosis I and multiple sclerosisChristina Bergqvist, François Hemery, Salah Ferkal, et al.
Journal of Medical Genetics|August 15, 2012
Neurofibromatosis type 1: from genotype to phenotypeEric Pasmant, Michel Vidaud, Dominique Vidaud, et al.
Contact Dermatitis|June 14, 2014
Contact dermatitis caused by ascorbyl tetraisopalmitate in a cream used for the management of atopic dermatitisHaudrey Assier, Pierre Wolkenstein, Catherine Grille, et al.
The Journal of Investigative Dermatology|February 28, 2025
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: How to Improve the Evaluation of Therapeutic StrategiesSaskia Ingen-Housz-Oro, Lars E French, Pierre Wolkenstein
The Journal of Investigative Dermatology|January 23, 2025
Need for Trial Design Change in Epidermal Necrolysis (Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis): Example of CyclosporineSaskia Ingen-Housz-Oro, Nicolas de Prost, Pierre Wolkenstein
Presse Medicale (Paris, France : 1983)|March 14, 2018
[Association of chromhidrosis and segmental neurofibromatosis]Charles Velter, Sylvie Thubert, Pierre Wolkenstein, et al.
Neuro-Oncology Advances|March 9, 2026
Disease burden and unmet needs in adults with neurofibromatosis type 1 and plexiform neurofibromas: A systematic literature reviewMaciej Mrugala, Ayo Adeyemi, Juliet Johns, et al.
Journal of the American Academy of Dermatology|November 14, 2006
Quality of life impairment in hidradenitis suppurativa: a study of 61 casesPierre Wolkenstein, Anderson Loundou, Karine Barrau, et al.
Orphanet Journal of Rare Diseases|May 20, 2021
Lymphoproliferative malignancies in patients with neurofibromatosis 1Christina Bergqvist, François Hemery, Arnaud Jannic, et al.
Pageof 23